Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT05641974 · ClinicalTrials.gov registry record · NA
Effect of Helpers Program On-line Training on Smoking Relapse and Social Networks
A NA study of Smoking and Cigarette Smoking, sponsored by University of Colorado, Denver.
- Active
- Registry status
- NA
- Development phase
- 940
- Enrollment target
- 1
- Study location
NCT05641974: Active NA study of Smoking and Cigarette Smoking, sponsored by University of Colorado, Denver.
NCT05641974 is a NA study of Smoking and Cigarette Smoking that is active but no longer recruiting, run by University of Colorado, Denver. The registered enrollment target is 940 participants, above the 447-participant average among 123 other Smoking trials with a reported enrollment target (110% higher). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT05641974, a NA study of Smoking and Cigarette Smoking, is active but no longer recruiting, sponsored by University of Colorado, Denver.
- ACTIVE NOT RECRUITING
- Registry status
- NA
- Development phase
- 940 participants
- Enrollment target
- 1
- Study location
Study Summary
The purpose of this study is to assess the effect of the Helpers Stay Quit training on abstinence over time of newly abstinent smokers, and on the interactions they have with their personal network related to smoking and smoking cessation.
Primary Outcome
Participants report the number of days (if any) they smoked combustible tobacco within the specified timeframe.
Conditions Studied
Interventions
- BEHAVIORAL Helpers Stay Quit Training
Study Locations (1)
Colorado
- University of Colorado Anschutz - Aurora
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 940 participants |
| Start Date | 2022-12-12 |
| Est. Completion | 2026-10-31 |
| Phase | NA |
What the registry record for NCT05641974 still lists
NCT05641974 is an interventional study that assigns participants to a tested intervention. The registered 940 participants enrollment target is mid-sized for trials with a published cap, above the 447-participant average among 123 other Smoking trials with a reported enrollment target (110% higher).
The record links to 2 conditions, with Smoking appearing as the primary indexed condition, and to 1 intervention - of which Helpers Stay Quit Training is the first listed.
NCT05641974 reports a single indexed study location in Colorado.
Frequently Asked Questions
What is clinical trial NCT05641974 about?
NCT05641974 is a clinical study titled "Effect of Helpers Program On-line Training on Smoking Relapse and Social Networks". The purpose of this study is to assess the effect of the Helpers Stay Quit training on abstinence over time of newly abstinent smokers, and on the interactions they have with their personal network related to smoking and smoking cessation.
What is the current status of trial NCT05641974?
This trial is currently active not recruiting. It is a NA study. The enrollment target is 940 participants. The study started on 2022-12-12. Estimated completion is 2026-10-31.
What conditions does trial NCT05641974 study?
This clinical trial studies the following conditions: Smoking, Cigarette Smoking.
What interventions are being tested in trial NCT05641974?
The interventions under investigation include: Helpers Stay Quit Training (BEHAVIORAL).
Who is sponsoring clinical trial NCT05641974?
This trial is sponsored by University of Colorado, Denver, which has 1,283 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT05641974 being conducted?
This trial has 1 study location across Colorado. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Smoking
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Where NCT05641974's enrollment target sits among peer trials
940 14th of 123 higher than 110 of 123 other Smoking trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Smoking trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
-
Clinical Alternatives for Reducing Harm Using E-cigarettes
RECRUITING · NA
-
Black Impact: The Mechanisms Underlying Psychosocial Stress Reduction in a Cardiovascular Health Intervention
RECRUITING · NA
-
Refer2Quit: Evaluating a Proactive, Tailored, Population Health Approach for Tobacco Treatment for Household Smokers Through a Pediatric Care Network
RECRUITING · NA
-
Enhancing Motivation to Quit Smoking Via Self-Help Intervention Targeted to Cancer Type
RECRUITING · NA
-
Personalized Tobacco Treatment in Primary Care (MOTIVATE)
RECRUITING · NA
-
Take A Break - Rural
RECRUITING · NA
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT03075696 · 940 participants · Phase 1
A Dose Escalation Study of Glofitamab (RO7082859) as a Single Agent and in Combination With Obinutuzumab, Administered After a Fixed, Single Pre-treatment Dose of Obinutuzumab in Participants With Relapsed/Refractory B-cell Non-hodgkin's Lymphoma
- NCT06855277 · 940 participants · Phase 3
Study Comparing AAA817+ARPI Versus Standard of Care in Adult Participants With PSMA-positive mCRPC
- NCT06808334 · 942 participants
CLAiR Pivotal Study
- NCT07190209 · 942 participants · Phase 3
Efficacy, Safety, and Tolerability Study of Lunsekimig Compared With Placebo in Adult Participants With Inadequately Controlled Chronic Obstructive Pulmonary Disease (COPD) Characterized by an Eosinophilic Phenotype
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI